Bone Biologics (BBLG) Depreciation & Amortization (CF) (2015 - 2019)
Bone Biologics (BBLG) reported Depreciation & Amortization (CF) of $26.0 for Q2 2019, up 8.33% year-over-year from $24.0 in Q2 2018, and up 8.33% quarter-over-quarter from $24.0 in Q1 2019.
Bone Biologics (BBLG) Depreciation & Amortization (CF) (2015 - 2019) Analysis & Trends
Bone Biologics (BBLG) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $26.0 in Q2 2019.
- Depreciation & Amortization (CF) for Q2 2019 came in at $26.0, up 8.33% year-over-year; the trailing twelve-month figure through Mar 2020 was $26.0 (down 72.92% YoY), and the FY2019 annual result was $50.0, down 47.92% from the prior year.
- Depreciation & Amortization (CF) grew to $26.0 in Q2 2019 per BBLG's latest filing, from $24.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $2739.0 in Q4 2015 and troughed at $24.0 in Q1 2017.
- A 5-year average of $299.61 and a median of $25.0 in 2017 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2016 and 2019: Depreciation & Amortization (CF) sank 98.54% in 2016, then climbed 8.33% in 2019.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $2739.0 in 2015, then slumped by 98.54% to $40.0 in 2016, then plunged by 40.0% to $24.0 in 2017, then changed by 0.0% to $24.0 in 2018, then advanced by 8.33% to $26.0 in 2019.
- Business Quant data shows BBLG's Depreciation & Amortization (CF) at $26.0 in Q2 2019, $24.0 in Q1 2019, and $24.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1,395.22 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 429,663.65 |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 26.00 |
| Jun 30, 2019 | 26.00 |
| Mar 31, 2019 | 24.00 |
| Mar 31, 2019 | 24.00 |
| Dec 31, 2018 | 24.00 |
| Dec 31, 2018 | 24.00 |
| Sep 30, 2018 | 24.00 |
| Sep 30, 2018 | 24.00 |
| Jun 30, 2018 | 24.00 |
| Jun 30, 2018 | 24.00 |
| Mar 31, 2018 | 24.00 |
| Mar 31, 2018 | 24.00 |
| Dec 31, 2017 | 24.00 |
| Dec 31, 2017 | 24.00 |
| Sep 30, 2017 | 24.00 |
| Sep 30, 2017 | 24.00 |
| Jun 30, 2017 | 24.00 |
| Jun 30, 2017 | 24.00 |
| Mar 31, 2017 | 24.00 |
| Mar 31, 2017 | 24.00 |